Pediatric Acute Lymphoblastic Leukemia Emerging Therapies—From Pathway to Target

Over the past 40 years, the 5-years-overall survival rate of pediatric cancer reached 75–80%, and for acute lymphoblastic leukemia (ALL), exceeded 90%. Leukemia continues to be a major cause of mortality and morbidity for specific patient populations, including infants, adolescents, and patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivanov, Anca Viorica, Alecsa, Mirabela Smaranda, Popescu, Roxana, Starcea, Magdalena Iuliana, Mocanu, Adriana Maria, Rusu, Cristina, Miron, Ingrith Crenguta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003692/
https://www.ncbi.nlm.nih.gov/pubmed/36902091
http://dx.doi.org/10.3390/ijms24054661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003692/
https://www.ncbi.nlm.nih.gov/pubmed/36902091
http://dx.doi.org/10.3390/ijms24054661

Ejemplares similares